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BACKGROUND AND AIM OF THE PROJECT                         
The standard long protocol GnRH agonist regimen is a well established 
strategy  for  controlled  ovarian  stimulation  (COS)  in  young 
normogonadotrophic women undergoing IVF/ICSI (Hughes et al., 1992; 
Tan  et al.,  1992). In such a protocol,  GnRH agonist administration is 
primarily followed by ‘monotherapy’ with highly purified urinary FSH 
(FSH-HP) or recombinant human FSH (r-FSH). Thus, endogenous LH 
secretion is suppressed with no exogenous LH activity. 
Nevertheless, this approach is effective in almost all women, suggesting 
that residual circulating levels of endogenous LH are usually adequate to 
support multiple follicular growth and oocyte development (Loumaye et 
al., 1997; Sills et al., 1999). About 12–14% of these patients treated with 
a  depot  GnRH agonist,  an  abnormal  ovarian  response  profile  to  this 
protocol is observed (De Placido  et al., 2001; 2004) . In particular, an 
initial follicular growth [at least six follicles ≥6 mm in diameter on the 
fifth day of stimulation in association with a ≥2-fold increase in estradiol 
(E2) levels with respect to the value observed on the day of pituitary 
suppression assessment]  is  followed by a  plateau phase,  in  which no 
significant change in follicular diameter and a suboptimal increase in E2 
levels are observed between days 5 and 8 of stimulation, despite the use 
of  age and body mass index (BMI)-appropriate dosage increase of  r-
FSH. This condition (steady response) usually leads to an increase in the 
r-FSH daily dose and results in a suboptimal ovarian response with a 
large  consumption  of  r-FSH.  It  has  been  recently  hypothesised  that 
suboptimal  ovarian  response  to  r-FSH may  also  be  due  to  excessive 
pituitary LH suppression. In such cases, an improvement in the ovarian 
outcome  from  LH-containing  gonadotrophin  preparations  would  be 
expected (Laml et al., 1999; Levy et al., 2000; De Placido et al., 2001, 
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2004).  This hypothesis is  consistent  with previous data demonstrating 
that in young normogonadotrophic patients undergoing a GnRH agonist 
long protocol, cycles displaying the above-mentioned pattern of initial 
steady  response  to  r-FSH  are  rescued  by  administering  HMG,  an 
extractive preparation of FSH and LH in a 1:1 ratio, from the eighth day 
of  stimulation.  The  use  of  hMG as  a  source  of  LH supplementation 
results in an increase in the FSH dosage as well. Interestingly, women 
who benefited from exogenous LH supplementation showed endogenous 
hormonal levels during the early stimulation that were comparable with 
those observed in age and BMI matched subjects showing an adequate 
response  to  monotherapy  with  r-FSH.  Taken  together,  these  data 
represented  the  first  clinical  evidence  of  the  need  for  LH 
supplementation in specific patient groups, despite the lack of a priori 
indications. Furthermore, these findings were consistent  with previous 
experimental  and  clinical  lines  of  evidence  indicating  that 
immunoreactive LH is not necessarily representative of LH bioactivity 
(Mitchell  et  al.,  1995).  With  the  recent  availability  of  recombinant 
human LH (r-LH), clinicians have the opportunity of administering the 
two gonadotrophins independently. Thus, exogenous LH administration 
may  be  calibrated  independently  of  r-FSH,  preliminary  prospective 
randomized trial demonstrated that a daily r-LH dose of 150 IU resulted 
in a significant increase in the mean number of oocytes retrieved when 
compared with 75 IU in women displaying steady response to r-FSH (De 
Placido et al., 2004).
In conclusion, the aim of the present project is to study the influence of 
different ovarian stimulations. 
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Based on this preliminary studies, the aim of this present projects is to 
study the:
- The  efficacy  of  a  supplementation  of  r-LH  versus  an  r-FSH  GnRH 
agonist long protocol in normogonadotrophic women with a normal and 
'steady response' to monotherapy with r-FSH on the maturity and number 
of recruited oocyte undergoing IVF cycles.  
- The  efficacy  of  a  supplementation  of  r-LH  on  oocyte  cytoplasmic 
maturity in terms of 'funnel effect' in normogonadotrophic women with a 
normal and 'steady response' to monotherapy with rFSH. 
- The importance of the oocyte scoring on zygotes and embryo quality in 
patients undergoing IVF/ICSI cycles.
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CHAPTER 1
LH effect on oocyte morphology and quality in normogonadotrophic 
“normal responders” to r-FSH patients
 
INTRODUCTION
Physiology of gonadotrophins
About 10% of the anterior hypotalamus is constituted by gonadotrophin 
cells. They produce two gonadotrophins, the luteinising hormone  (LH) 
and the follicle stimulating hormone (FSH).  Analogously to the thyroid 
stimulating hormone  (TSH)  and to the  human chorionic gonadotrophin 
(hCG),  LH and FSH  are two glycoprotein hormones characterized by 
two subunit α e  β. The α subunit is common to all these glycoprotein 
hormones, while the specificity is conferred by the subunit  β, coded by 
various  genes.  The synthesis  and release of  the gonadotrophins are  a 
phenomena regulated in a dynamic manner. This can be seen particularly 
in woman whose changes in levels rapidly fluctuate during a menstrual 
cycle.  The  hypothalamic  releasing  factor  of  gonadotrophins 
[gonadotrophin releasing hormone (GnRH)], consist of a 10 aminoacids 
peptide synthesized in the preoptic area, which regulates the synthesis 
and the  secretion  of  both gonadotrophins.  GnRH secretion  is  pulsatil 
within a 60-120 minutes interval, such impulses, determine those of LH 
and FSH. The GnRH acts through a receptor combined with a G protein 
which,  once  divided,  activates  the  phosfolipase  and proteinkhinase  C 
pathway, in addition to intracellular calcium. GnRH pulsatile secretion is 
very  important  since  it  determines  the  priming  of  the  gonadotrophin 
cells,  while  its  continuous  production  causes  desensibilization.  The 
GnRH analogous (GnRH-a) are used when continous administration is 
required, in order to suppress the pulsatility action of the gonadotrophins 
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in: children with premature puberty, in men with prostate cancer, women 
with  endometriosi  (I-IV  stage)  and  in  the  treatment  of  the  uterine 
fibroids. GnRH analogous are also used in some stimulation induction 
protocols in order to reduce endogenous gonadotrophin production and 
thus  allow  exogenous  hormonal  control.  The  estrogens  on  the 
hypothalamic and hypofisary level in order to regulate the gonadotrophic 
secrection.  Indeed,  a  chronic  exposure  to  estrogens  has  an  inhibitory 
effect either on the hypothalam or hypofisary function. Increasing levels 
of estrogens, as can be observed during the pre-ovulatory peak stimulate 
a  positive  feedback,  thus  increasing  the  range  and  the  frequency  of 
gonadotrophin  secrection.  On  the  contrary,  progesterone  reduces 
pulsation frequency, and adversely enhances gonadotrophin response at 
GnRH.
Eventhough GnRH is the principal factor in LH and FSH regulation and 
secrection,  its  synthesis  is  controlled  by  activin  and  inhibin.  The 
aforementioned belong to  the family of  the growth factors  (TGF- β). 
Inhibin acts selectively in opposition to FSH secrection, while activin 
stimulates its synthesis. Gonadotrophins, binding to receptors expressed 
on  the  ovary  and  testicle,  respectively,  induce  the  germinal  cell 
development and maturity, thus increasing the biosynthesis of the sexual 
hormones. In women, FSH regulates follicle development and stimulates 
the  estrogen  production  in  the  ovary.  Instead,  LH  is  responsible  for 
ovulation and maintenance of the luteal phase. In man, LH induces the 
synthesis and the secrection of testosterone via Leydig cells, while FSH 
stimulates  the  development  of  seminiferous  tubules  and  regulates 
spermatogenesis.
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1.2 Role of FSH and LH in folliculogenesis
FSH has a key role in reproductive function: in males it is essential for 
Sertoli cell function and spermatogenesis,  and in females it stimulates 
the growth of  a large pre-ovulatory follicle  that,  because of  its  FSH-
dependent maturation, is able to.ovulate and to form a corpus luteum in 
response to the mid-cycle surge of LH. 
Follicle  development  from  the  primordial  to  the  pre-ovulatory  stage 
takes several months (Gougeon, 1996). The initiation of growth of the 
primordial  follicles  takes  place  continuously  and  it  appears  to  be 
independent of pituitary gonadotrophins. In vitro studies show that other 
factors  are  probably  involved  in  the  early  stages  of  follicular 
development  and  apoptosis  (programmed  cell  death):  activin, 
transforming growth factor- β, bone morphogenetic proteins, growth and 
differentiation factor-p,  oestrogens,  androgens,  insulin  and insulin-like 
growth factor-I (Miro and Hillier 1996; Touraine et al., 1999; McGee 
and  Hsueh  2000;  Zeleznik  2004).  The  role  of  these  factors  in  vivo 
remains uncertain. 
Early antral follicles become FSH responsive and constitute a pool of 
available follicles that can be stimulated to growth. The final destiny of 
the majority of these follicles will be atresia, except for a single follicle 
that will grow until final maturation to the pre-ovulatory stage. 
At the end of the luteal phase, early antral follicles (2-5 mm in diameter) 
are  present.  Granulosa cells  of  these  early  antral  follicles  seem more 
sensitive to FSH stimulation.
During the luteo-follicular transition, due to the demise of the corpus-
luteum and the subsequent decrease in oestrogen production, the FSH 
serum concentration rises (perimenstrual rise), maintaining a plateau in 
the  first  days  of  the  follicular  phase.  FSH must  reach a  threshold:  a 
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critical concentration of FSH must be achieved to initiate the process of 
follicular development. In anovulatory women changes  of 10-30% are 
sufficient to initiate follicular development (Brown, 1978).
From mid-follicular through late-follicular phase, follicular selection is 
achieved:  granulosa  cells  acquire  aromatase  activity.  This  enzymatic 
activity leads to a rise in oestradiol (and inhibin) and, as a consequence, 
a progressive fall in FSH serum concentration (negative feed-back). The 
mid-follicular  fall  in FSH concentration determines the atresia of less 
mature  follicles  that  are  unable  to  grow  without  adequate  FSH 
concentrations.  The  maturing  selected  follicle  continue  to  develop 
because it acquires less dependency on FSH by increased sensitivity to 
FSH  itself.  It  has  been  demonstrated  that  FSH induces  LH receptor 
formation  on  pre-ovulatory  follicle  granulosa  cells  (Zeleznik et  al., 
1981).  The action of LH on its receptors activates adenyl cyclase: the 
consequent production of cAMP represents an additive response to FSH 
(Goff  et  al., 1977).  Therefore,  the  maturing  follicle  reduces  its 
dependency on FSH by acquiring LH receptors and LH responsiveness 
(Fauser  and Van Heusden 1997;  Willis  et  al., 1998;  Campbell  et  al., 
1999; Sullivan et  al., 1999; Filicori  et  al., 2002).  On the other  hand, 
lower concentrations of FSH bring less mature follicles to atresia. The 
granulosa cells from early antral follicles are only responsive to FSH; 
granulosa cells  from FSH-stimulated follicles  are  responsive to either 
FSH or LH (Zeleznik and Hillier, 1984). 
LH plays a key role in the intermediate-late phases of folliculogenesis. 
According to the 'two-cells-two- gonadotrophin's model (Fevold, 1941; 
Hillier  et  al.,  1994) LH  plays  a  key  role  not  only  in  theca  cell 
steroidogenesis stimulation, but also in follicle growth and maturation. 
LH exerts its activity in theca cells, which form the involucres of the 
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growing  follicles  and  express  enzymatic  pathways  of  androgen 
synthesis. The theca wall surrounds the granulosa cells, whose activities 
and proliferation are directly regulated by FSH. This hormone induces 
the expression of the aromatase enzyme which in turn, converts theca-
deriving androgens into oestradiol. This theory reinforced the notion that 
granulosa and theca cells are distinct compartments regulated by FSH 
and LH respectively. However, it was subsequently found, in different 
line  research,  that  LH  receptors  are  detectable  on  the  granulosa 
compartment  (Shima et al.,  1987) at the intermediate follicular phase 
(Erickson  et  al.,  1979;  Filicori  et  al.,  2003a),  at  a  time  when  blood 
concentrations  of  LH increase.  In  particular  both  oestradiol  and FSH 
seem  to  cooperate  in  inducing  the  expression  of  these  receptors. 
Therefore, it appears that LH regulates both granulosa and theca cells. 
FSH and LH induce the local production of the soluble molecule inhibin 
B and growth factors. Among these, insulin-like growth factors (IGF)-1 
and -2, which are expressed by both granulosa and theca cells throughout 
folliculogenesis, are important in promoting follicular maturation (Zhou 
and Bondy, 1993;  Huang et  al.,  1994).  Thus,  gonadotrophins and the 
autocrine-paracrine  system  contribute  to  the  complex  mechanisms 
governing  follicular  growth  and  selection.  The  finding  that  both 
gonadotrophins also regulate granulosa cell activity suggests that LH is 
involved  in  inducing  and  maintaining  this  paracrine  system  of 
biochemical factors by acting on the theca and granulosa compartments. 
These findings may explain the observation that  FSH activity  can be 
totally substituted by LH once granulosa cells express adequate amounts 
of LH receptors (Zeleznik and Hillier, 1984; Filicori et al., 2002). 
Hence, LH seems to play two roles during folliculogenesis. The first one 
consists  of  an  induction  of  androgen production  exerted  in  the  theca 
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compartment. The second one, consists of inducing the local production 
of various molecules that begins during the intermediate follicular phase 
(Willis et al., 1998; Filicori et al., 2003a) and involves granulosa cells. 
These  factors  promote  the  growth  of  granulosa  cells  which  in  turn, 
regulate oocyte maturation. These two mechanisms are closely related 
and  probably  support  one  another. This  observation  also  leads  to 
hypothesise  that  these  paracrine  activities  are  able  to  enhance  LH 
activity on theca compartment: according to the so called 'spare receptor 
hypothesis' (Chappel and Howles, 1991), when inhibin B and IGF-l are 
adequate1y secreted, androgen synthesis and release are optimal even if 
less than 1% of LH receptors are occupied. LH has been implicated in a 
third process during folliculogenesis. In particular, it has been suggested 
that  this  hormone may contribute  negatively on the selection of  non-
dominant  follicles.  This  idea  was  based  on  the  observation  that, 
folIowing the mid-cycle LH surge, granulosa cell mitosis is blocked and 
oocyte meiosis is resumed (Shoham et al.,  1995). Preclinical evidence 
showed that developing follicles have specific requirements for exposure 
to LH beyond which,  normal maturation ceases (Hillier  et  al.,  1994). 
This finding gave rise to the concept of an 'LH ceiling', meaning that, 
each follicle would have an upper lirnit of stimulation. The LH ceiling 
may  be  higher  in  larger  follicles  and  lower  in  smaller  ones.  As  a 
consequence,  an  increasing  LH concentration  would  promote  leading 
follicle  progression  (being  below  its  ceiling)  and  degeneration  of 
secondary  ones  (by  overcoming their  ceiling).  According to  others,  a 
dynamic  interplay  between  LH  secretion  and  receptor  expression  by 
different  ovarian  compartments,  governs  the  selection  of  dominant 
follicles.  Due to the fact that small follicles in granulosa cells do not 
express LH receptors, LH may indirectly promote their degeneration.
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1.3 LH and ovarian stimulations
The gold standard for ovarian stimulation in young, normogonadotrophic 
women is the gonadotrophin-releasing hormone agonist (GnRH-a) long 
protocol  (Hughes  et  al.,  1992).  Exogenous  FSH is  administered  only 
when a  GnRH-a  mediated  suppression  of  the  hypothalamus-pituitary-
gonad  axis  is  achieved.  Moreover,  monotherapy  with  recombinant 
human FSH (r-FSH), which is free of LH activity, is used in most cases. 
The  degree  of  pituitary  suppression  also  depends  on  the  GnRH-a 
formulation, dose and way of administration (Westergaard et al., 2001). 
Following  suppression,  LH concentrations  usually  range  between  0.5 
and 2.5 IU/l.  These concentrations  often fall  by <0.5 IU/l  during the 
intermediate late stages of stimulation. Thus, multiple follicular growth 
is  often  induced  in  a  low endogenous  LH environment,  an  adequate 
ovarian response is achieved in almost all patients. 
A hiatus appears to exist between IVF practice and information deriving 
from folliculogenesis models and hypogonadotrophic hypogonadism. In 
particular, in the former situation, follicular growth normally occurs even 
when LH concentrations are below 0.5 IU/l. In contrast, there is evidence 
that  in  women  with  hypogonadotrophic  hypogonadism,  LH 
concentrations  of  1.2  IU/l  are  required  in  order  to  achieve  adequate 
ovarian  response  to  r-hFSH.  These  discrepancies  can be  attributed to 
biological  events  that  involve  steroidogenic  dynamics  and  follicular 
growth.  Regarding  stimulated  cycles,  the  'spare  receptor  hypothesis' 
(Chappel  and  Howles,  1991)  can  be  invoked:  even  when  pituitary 
desensitization is achieved, circulating concentrations of LH are able to 
occupy  an  adequate  percentage  of  receptors  and  to  elicit  sufficient 
androgen  release.  FSH-dependent  paracrine  activities,  including  the 
production of inhibins and IGF-l, may favour adaptation mechanisrns by 
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enhancing theca sensitivity to LH. In this context, a low LH environment 
would be advantageous during stimulation, LH-induced suppression of 
small follicles is not required. Furthermore, during the early-intermediate 
stages of follicular growth, low LH concentrations have been associated 
with a more physiological endometrial proliferation, which in turn seems 
to  synchronize  this  compartment  for  successive  embryo  implantation 
(Kolibianakis et al., 2004). 
At  the present  time,  due to  the low number  of  published studies,  no 
definite conclusion can be drawn regarding r-LH adjunctive treatment 
effectiveness.  It  has  been  suggested  that  the  use  of  LH  adjunctive 
therapy  in  late  follicular  phase  could  be  helpful  in  'hyporesponsive' 
patients.  These  patients  need  more  FSH ampoules  and  more  days  of 
treatment  to  achieve  adequate  follicular  growth  compared  with 
normoresponsive patients.  This  favourable  effect  of  exogenous LH in 
this subgroup of patients might be due to an excessive suppression in 
endogenous LH concentrations due to GnRH agonist or antagonist co-
treatment (Ferraretti  et  al.,  2004; De Placido et  al.,  2005).  A possible 
beneficial  role  has  also  been suggested  in  patients  over  35 years  old 
(Marrs  et  al.,  2004).  LH co-treatment  has  also  been  studied  in  poor 
responder patients, but apparently with no benefit (Chung et al., 2005). 
13
1.4 MII Oocyte assessment
Metaphase II oocytes collected from patients following ovarian stimula­
tion show a variety in morphological characteristics. The most important 
processes that should be completed in a well-coordinated and synchron­
ized manner are the nuclear and cytoplasmic maturation. Both types of 
maturation are highly susceptible to failures in hormonal supply and/or 
in-vitro culture conditions (e.g. pH, temperature, oxygen) that may cause 
alterations in oocyte morphology, with some of these anomalies being 
visible at light-microscopic level (Gaulden et al., 1992; Van Blerkom et 
al., 1997; Hu et al., 2001). Nuclear maturity is shown by the resumption 
of  meiosis  and  the  progression  to  metaphase  II,  the  natural  arresting 
point prior to ovulation. Two molecules have been identified supporting 
the transition from G2 to M phase of the cell cycle, cyclin B and p34 cdc2. 
Soon after p34cdc2 dephosphorylation, they associate and form the matur­
ation promoting factor (MPF) (Norbury and Nurse, 1992). Active MPF 
activate nuclear maturation (e.g. germinal vesicle breakdown) and con­
densation of metaphase I chromosomes. A second peak in MPF activity 
will then drive the oocyte to metaphase II (Eppig, 1996). Although oo­
cyte are competent to complete nuclear maturation, they could still be 
deficient in cytoplasmic maturation. Both of which are important for oo­
cyte activation, adequate fertilization, as well as, further preimplantation 
development. Studies on human and animal models show that the gam­
ete has to obtain competence to release intracellular stores of calcium 
(hamster;  Fujiwara et  al.,  1993)  and cortical  granules (mouse;  Eppig, 
1996);  glutathione  concentration  has  to  be  increased  (pig;  Yoshida, 
1993), and special patterns of active mitochondria have to be expressed 
(Wilding et al., 2001; Barritt et al., 2002). Asynchrony of these processes 
may  result  in  different  morphological  abnormalities,  depending  on 
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whether nuclear or cytoplasmic maturation has been affected. In this re­
spect, it has been suggested that dysmorphic features occurring in early 
meiotic maturation, may be associated with a higher frequency of an­
euploidy and fertilization failure, while, those occurring in late matura­
tion may cause a higher incidence of developmental failure. In fact, more 
than half  of the gametes collected show morphological  abnormalities, 
some of which seem to be correlated with an impaired outcome (e.g. ag­
gregation of endoplasmic reticulum, vacuolization, increased ooplasmic 
viscosity, giant eggs). Therefore, it is strongly recommended to include 
oocyte quality in all scoring systems applied in IVF laboratories. 
The most distinctive parameter for oocytes that did not resume meiosis, 
is the presence of the prophase I germinal vesicle (GV), which identifies 
the  cohort  with  a  diploid  chromosomal  set.  After  GV  breakdown, 
oocytes reach metaphase l stage characterized by the absence of the first 
polar body extrusion.  Though some of these intermediate oocyte may 
even be fertilizable (De Vos et al., 1999), the formation of the first polar 
body is the only prognostic factor to assume that a gamete has completed 
nuclear maturation, i.e. showing a haploid set of chromosomes.
First polar body
As a result  of  a normal hormonal  ovulation induction,  at  the time of 
oocyte retrieval, most of the oocytes should have a regular size and a 
correct nuclear maturation, showned by the extrusion of the first polar 
body  in  the  perivitelline  space.  Though  some  first  polar  bodies  in 
humans  remain  intact  for  more  than  20h  after  ovulation,  first  polar 
bodies in eutherian mammals generally have a shorter life (Ortiz et al., 
1983). Taking this time dependency into consideration one may postulate 
that first polar body morphology provides adequate information on the 
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actual  post-ovulatory  age  of  the  corresponding  oocyte.  (Xia,  1997) 
analysed fertilization rate and embryo quality in oocytes with varying 
perivitelline space size and first  polar body appearance.  In this study, 
optimal oocytes were characterized by an intact first polar body and a 
small perivitelline space. Ebner (2000) group tried to focus exclusively 
on  the  status  of  the  first  polar  body.  The  data  obtained indicate  that 
oocytes  with  an  intact  well-shaped  first  polar  body  yield  better 
fertilization  rates  and  embryo  quality.  This  in  turn  gives  higher 
implantation and pregnancy rates (Ebner et al., 1999).  However, in other 
works neither fertilization rate, embryo quality or outcome were found to 
be affected (Ciotti et al., 2004; De Santis et al., 2005). It has to be taken 
into account that in this paper intracytoplasmic sperm injection (ICSI) 
was performed up to 9h after oocyte collection, a situation that is hardly 
comparable to  previous work (Xia,  1997; Ebner et  al.,  2000;  2002a). 
Verlinsky's group (Verlinsky et al., 2003)  genetically analysed embryos 
deriving from different polar body classes. As expected, no correlation 
was  observed  between  polar  body  shape  and  genetic  constitution; 
however,  the  only  polar  body  group  bearing  a  theoretical  risk  of 
chromosomal  disorder,  considering  the  larger  volume of  ooplasma in 
huge polar bodies, was not analysed. 
Interestingly,  oocytes showing a first  polar body some times may not 
have finished nuclear maturation. In fact, it has been found that human 
oocytes with a polar body but without a birefringent spindle may still be 
at telophase I or prometaphase I stage (Eichenlaub-Ritter et al., 2002; De 
Santis et al., 2005). 
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MATERIALS AND METHODS
2.1 Patients
Among candidates for IVF–embryo transfer or ICSI cycles, only patients 
aged 18–37 years,  with menstrual  cycles ranging from 24 to 35 days 
(intra-individual variability ±3 days), basal FSH (day 3 of a spontaneous 
menstrual cycle) concentrations ≤9 IU/l, and hysteroscopic evidence of a 
normal  uterine  cavity  within  the  last  6  months  were  included.  In 
addition,  only  women  undergoing  a  GnRH  agonist  long  protocol 
followed by rFSH administration were enrolled. 
The following exclusion criteria will be adopted: body mass index [BMI 
═ weight  (kg)/height  (m2)]  <18.0  and  >28.0,  biochemical  and/or 
ultrasonographic  evidence  of  polycystic  ovarian  syndrome  (PCOS), 
stage III–IV endometriosis according to the rAFS (1985), chromosomal 
abnormalities, endocrinological and/or autoimmune disorders, more than 
two previously unsuccessful IVF or ICSI cycles, and presence of only 
one  ovary.  Moreover,  patients  who displayed one  to  four  follicles  of 
diameter  >10mm or no follicle >10mm but serum E2 levels ≥180 pg/ml 
on day 8 of stimulation.
A prospective  randomized controlled  trial  will  be  conducted.  Patients 
with a normal response to rFSH will  be randomized to two treatment 
groups : the first one undergoing an rFSH protocol (group A), the second 
one  undergoing  an  r-LH  protocol  (group  B).  Cinicians  will  perform 
oocyte collection and I will observe oocyte morphology of each group.
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2.1 Ovarian stimulation protocols
All  patients  will  undergo  a  GnRH  agonist  long  protocol,  a  well 
established  strategy  for  COS  in  young,  normogonadotrophic  women 
(Hughes  et  al.,  1992).  Pituitary  desensitization  was  induced  with  the 
administration  of  the  GnRH  agonist  triptorelin  (Decapeptyl  3.75  mg 
depot; Ipsen S.P.A, Italy) on the first day of the menstrual cycle. After 15 
days,  patients  undergo  transvaginal  ultrasound  evaluation  and 
biochemical evaluations. Subjects showing serum  E2 level  ≤40 pg/ml, 
endometrial thickness  ≤5mm and arrested follicular development started 
gonadotrophin  administration.  Women  with  delayed  suppression 
(including subjects who developed ovarian cysts after the GnRH agonist 
administration) will be excluded from the study. A fixed daily dose of 
150 IU of rFSH (Gonal-F; Serono Pharma, Italy) was administered. On 
the fifth day of stimulation, serum E2 levels were measured and the daily 
rFSH dose was reduced by 75 IU in patients  showing concentrations 
>180 pg/ml.  On the eighth day of stimulation serum E2  concentrations 
will  be measured and follicular growth monitored with a transvaginal 
scan, and thereafter on alternate days until hCG will be administered. 
Patients satisfying inclusion and exclusion criteria and characterized by a 
tripling of serum E2  levels between  days 5 and 8, and with more than 
four follicles  >10mm in diameter on day 8, will continue current rFSH 
dose and the other group will add r-LH to their stimulation protocol. 
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2.3 Oocyte maturity evaluation
Oocytes  had been retrieved  under  conscious  sedation  by  transvaginal 
ultrasound-guided  aspiration  35-36  h  after  the  hCG  injection.  After 
incubation for 2-4 h in drops of IVF medium under oil at 37°C and 5% 
CO2 incubator, oocyte are going to be expose to 80 IU/ml hyaluronidase 
(MediCult,  Copenhagen,  Denmark) facilitating mechanical  removal of 
the cumulus cells.(Ebner et al., 2001). At this time every oocyte will be 
separate  in  numbered  drops  and  will  be  evaluated,  under  inverted 
microscope equipped with a Hoffman, for maturation stage metaphase II 
(MIl), metaphase I (MI) or germinal vesicle (GV).
2.4 Statistical analysis
The results are reported as the mean ± SD. Data were analysed with the 
SPSS version 12.0 (SPSS Inc.,  USA).  One-way ANOVA was used to 
determine the effect of the stimulation protocol on continuous variables. 
The post hoc The Mann–Whitney U-test was applied to test differences 
between  groups  for  continuous  variables  with  non-parametric 
distributions. 2  statistics were used to compare discontinuous data. A p 
value <0.05 was considered statistically significant.
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RESULTS
Demographic,  anthropometric  and  hormonal  characteristics  were 
comparable between groups (Table  1). A total of 247 oocyte in the and 
194 oocyte in group B were collected. Patients treated with r-hFSH plus 
r-hLH showed a significantly  higher percentage of mature oocytes (p 
<0.025) (Table 2).   In order to evaluate if r-hLH may differently affect 
oocyte quality according to age, patients were “a posteriori” divided in 
two subgroups:   women ≤30 years   constituted the group 1,  whereas 
patients  >30  represented  group  2.  Thus,  four  subgroups  have  been 
identified: subgroup 1A (n = 12) included younger women treated with r-
FSH; subgroup 1B (n = 11) was constituted by young patients stimulated 
with r-FSH plus r-LH. Women >30 years treated with r-FSH and r-FSH 
plus r-LH were included in the groups 2A (n =  10) and 2B (n  = 9), 
respectively. Demographic, anthropometric and hormonal characteristics 
among  groups  were  similar  (data  not  shown).  Comparisons  of 
percentages of mature oocytes between groups 1A and 1B and between 
2A and 2 B are shown in tables 3 and 4, respectively.
20
        
Table 1. Characteristics of the two study groups
Numbers are mean ± SDs, except where differently indicated. One-way 
ANOVA  was  adopted  for  continuous  variables.  No  statistically 
difference was revealed between groups for each of the analyzed.
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Characteristic Group A 
 (n =  22) 
 Group B
 (n =  20)
Age (years) 32.6 ± 3.4 33.9 ± 3.7
Body Mass Index [weight(kg)/ 
height(m)2]
24.6 ± 3.2 24.2 ± 3.4
Duration of infertility (years) 3.1 ± 0.91 2.9 ±  1.1
Basal FSH (IU/l) 6.9 ± 2.8 6.2 ± 1.9
Basal LH (IU/l) 4.7 ± 1.4 4.9 ± 1.2
Basal Estradiol (pg/ml) 52.7 ± 15.9 48.1 ± 17.4
 Group A (r-FSH) Group B (r-FSH + r-LH) 
N° oocyte retrieved                 247 194
Percentage of MII 
oocyte* (n)
           76.5 (189)               23.5 (165)
Table 2. MII Oocyte distribution in the two groups
*Χ2 p = 0.03
Group 1A (r-FSH) Group 1B (r-LH)
N° oocyte retrieved 114 99
Percentage of MII 
oocytes* (n)
75.4 (86) 24.6 (80)
Table 3. Impact of different gonadotrophins on patients ≤30 years
*Χ2 p = 0.43
Table 4. Impact of different gonadotrophins on patients >30 years
*Χ2 p = 0.03
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Group 2A (r-FSH) Group 2B (r-LH)
N° oocyte retrieved 133 95
Percentage of MII 
oocytes* (n)
                  77.4 (103)                       89.5 (85)
CHAPTER 2
LH effect  on oocyte cytoplasmic quality in terms of “funnel effect” 
in normogonadotrophic “normal responders” to r-FSH patients
INTRODUCTION
Oocyte cytoplasm 
Cytoplasmic  maturation  involves  numerous  metabolic  and  structural 
modifications in  preparation for  subsequent  fertilization (Eppig et  al., 
1994).
Extensive cytoplasmic granularity may either be homogeneous, affecting 
the whole gamete, or centrally located. The latter was found to be negat­
ively correlated with ongoing pregnancy rate (Kahraman et al., 2000). In 
contrast, slight or moderate granularity has been accepted as a normal 
feature of oocytes. It  is conceivable that an increased viscosity of the 
cytoplasm may constrain cell organelles and/or pronuclei in their move­
ment preventing the zygote from achieving alignment of both pronuclei 
or  alignment  of  pronuclei  with  respect  to  the  polar  bodies,  thereby 
severely  impairing  polarity  and  further  preimplantation  development 
(Edwards and Beard, 1997; Garello et al., 1999). Though it has been re­
ported that granular areas are more viscous than the surrounding cyto­
plasm (Payne et al., 1997) there is a lack of markers of increased cyto­
plasmic viscosity.  MII oocytes of good morphology should show a clear 
and colourless cytoplasm with moderate granulation and no inclusions; 
however, more than half of all human (Ebner et al., 2003a), as well as 
primate oocytes (Suzuki et al., 2004), show at least one morphological 
abnormality. Intracellular pressure and ooplasm fluidity can only be es­
timated by the extent  to which the ooplasm rises within the injection 
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pipette immediately following penetration of the oolemma. Ooplasm of 
higher viscosity is  more likely to adhere to the spike of the injection 
pipette (Ebner et al., 2001) and the persistence of the injection funnel 
after ICSI may reflect a deficiency in cytoplasmic texture. The injection 
funnel is likely to be responsible for sealing the breach during injection 
(Kimura and Yanagimachi, 1995; Palermo et al., 1996). The absence of 
such a protective mechanism in oocytes with sudden breakage (without 
any injection funnel  at  all)  causes an increase in oocyte degeneration 
(Palermo et al., 1996; Ebner et al., 2001). Increased viscosity of the cyto­
plasm (persistent  funnel)  may  keep it  from leakage,  whereas  oocytes 
with more aqueous cytoplasm may tend to leak more frequently after in­
tracytoplasmic  oocyte  injection  (ICSI). Altered  flux  characteristics  of 
cytoplasm does  not  allow the  oocyte  to  restore  its  original  spherical 
shape after the sprematozoon injection as fast as it is seen in gametes 
with a more aqueous ooplasm. This phenomenon is possibly due to a de­
creased fluidity of the cytoplasm, which may result in a reduced intracel­
lular  pressure.  Since  differences  in  ooplasm viscosity  have  been  ob­
served (Payne et al., 1997) it is possible that alterations in viscosity may 
delay abuttal of pronuclei by severely impairing microtubule organiza­
tion. In contrast, a more fluid cytoplasm would promote optimal condi­
tions in preparation for further preimplantation development. As a con­
sequence,  viscous  oocyte  had  a  negative  influence  on  developmental 
competence since zygotes quality (optimal pronuclear pattern, presence 
of a halo) was severely impaired (Ebner et al., 2003b).
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MATERIALS AND METHODS
Patients
For this study, only patients aged 18–37 years,  with menstrual cycles 
ranging from 24 to 35 days (intra-individual variability ±3 days), basal 
FSH (day 3 of a spontaneous menstrual cycle) concentrations  ≤9 IU/l, 
and hysteroscopic evidence of a normal uterine cavity within the last 6 
months were  included.  In  addition,  only women undergoing a  GnRH 
agonist long protocol followed by rFSH administration were enrolled. 
Exclusion  criteria  and  ovarian  stimulation  protocol  had  already  been 
specified in chapter 1.
ICSI procedure
Oocytes had been retrieved as shown in chapter 1. The three best oocyte 
will  be  injected  with the  spermatozoon while  the  remaining one  will 
undergo  a  MOCK  ICSI.  With  this  procedure  we  can  observe  the 
presence of a ‘funnel effect’ without injecting a spermatozoon. The ICSI 
procedure is carried out by using an  injection pipette with an angle of 
approximately 30° with a 2  μm spike. A 140° bend at 1 mm from the 
pipette  permitted  the  terminal  end of  both  pipettes  to  operate  almost 
parallel to the bottom of the injection dish. The oocyte was held in place 
by the holding pipette via suction on the  zona pellucida at  9 o'clock, 
maintaining the inferior pole of the oocyte in contact with the dish as an 
additional point of support while injecting the pipette at 3 o'clock.
Funnel effect assessment
For  this  study,  one  embryologist  performed  the  ICSI,  while  another 
observed the procedure on a video and recorded the membrane patter of 
each oocyte. The spike and initial part of the bevel then pierced the inner 
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surface of the zona and came in contact with the oolemma. At this point, 
we observed two distinct patterns of membrane reaction. In some cases, 
the tip penetrating the membrane brakes the oolemma without creating a 
funnel,  which  we termed 'easy  breakage'.  Sometimes,  the  penetration 
proceeded normally to 9 o'clock, creating a funnel-shaped invagination 
and the  membrane  ruptured  at  the  approximate  centre  of  the  oocyte, 
which we termed 'normal breakage'.
Statistical analysis
The results are reported as the mean ± SD. Data were analysed with the 
SPSS version 12.0 (SPSS Inc., USA). Statistical analysis was performed 
as  described  in  the  chapter  1.  A  p value  <0.05  was  considered 
statistically significant.
26
Fig. 1 Presence of a funnel effect in an injected MII oocyte
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RESULTS
Characteristics of study were comparable as reported in Table 1. 
In a total of 135 and 159 oocytes in the groups A and B, respectively, the 
group B displayed a statistically significant increase in the percentage of 
oocytes with funnel effect (Table 5).
Also  in  this  case  the  hypothesis  that  r-LH differently  affects  oocyte 
quality according to age has been evaluated and whole study population 
was divided into two subgroups:  women ≤30 years constituted the group 
1,  whereas  patients  >30  represented  the  group  2.  Moreover,  four 
subgroups have been identified: subgroup 1A (n = 12): younger women 
treated with r-FSH; subgroup 1B (n  = 11):  young patients  stimulated 
with r-FSH plus r-LH. Women >30 years treated with r-FSH plus r-LH 
were included in the groups 2A (n  = 10) and 2B (n  = 9), respectively. 
Demographic,  anthropometric  and  hormonal  characteristics  among 
groups were similar (data not shown). Comparisons of percentages of the 
oocytes presenting funnel effect between groups 1A and 1B and between 
2A and 2B are shown in table 6 and 7, respectively.
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 Table 5. Presence of a funnel effect in MII injected oocyte
*Χ2 p = 0.04
Group 1A (r-FSH) Group 1B (r-LH)
N° injected oocyte 72 80
Percentage of oocyte 
presenting funnel 
effect* (n)
          70.8 (51)              76.3 (61)
            
       Table 6. Presence of a funnel effect in patients ≤ 30 years  
           
*Χ2 p = 0.57
Group 2A (r-FSH) Group 2B (r-LH)
N° injected oocyte 63 69
Percentage of oocyte 
presenting funnel 
effect* (n)
66.7 (42)    78.5 (62)
  
              Table 7. Presence of a funnel effect in patients >30 years
 *Χ2 p = 0.43
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Group A (r-FSH) Group B (r-LH)
N° injected oocyte 135 159
Percentage of oocyte 
presenting funnel 
effect* (n)
 66 (89) 76.7 (122)
DISCUSSION CHAPTERS 1 AND 2
In  the  first  chapters  of  this  work,  we  investigated  on  the  effects  of 
different  types  of  ovarian  stimulation  on  folliculogenesis.  More 
specifically, two protocols have been tested: monotherapy with r-FSH 
versus an association of r-FSH and r-LH. In this context, oocyte quality 
has been our endopoint. In the first phase of the study, we considered 
only the percentage of mature oocytes. This choice was related to the 
fact that high percentage of MII oocytes is considered a reliable marker 
of adequate folliculogenesis and a good prognostic factor for IVF. The 
main finding of this experimental phase was the statistically significant 
increase in the percentage of MII oocytes in the group treated with r-LH. 
This  observation  should  be  carefully  interpreted  due  to  the  relatively 
small  study  population.  Nevertheless,  it  may  represent  interesting 
information in the complex puzzle of clinical research on LH activity 
during ovarian stimulation. In fact, most recent RCTs failed to show that 
r-LH supplementation can significantly increase implantation rate when 
compared  with  r-FSH  monotherapy,  at  least  in  unselected  patients. 
Nevertheless,  taken  together  these  studies  showed  a  relevant  trend 
toward an increase in implantation rate in women undergoing r-FSH plus 
r-LH (Marrs  et  al.,  2004;  Humaidan  et  al.,  2004;  Lisi  et  al.,  2005). 
Implantation represents the effect of different steps in which a plethora 
of confounders can be introduced. As a consequence, huge sample size 
could be required to definitively understand the impact of r-LH. In this 
context, the evidence that r-LH can improve the quality of oocytes can 
be  relevant.  Following  confirmation  of  our  data,  researches  can  be 
encouraged to continue to compare the two protocols to reach sample 
size able to point out the real impact of improved oocytes on outcome of 
30
IVF.
In the second chapter, another endopoint was proposed. In particular, the 
so  called  “funnel  effect”  has  been  proposed  as  functional  marker  of 
gamete quality.  The execution of ICSI requires the penetration of  the 
zona  pellucida and  oolemma  with  a  sharp  glass  tool  -  the  injection 
pipette. Once the tip of this pipette reaches the perivitelline space and 
enters the membrane, two distinct membrane response patterns can be 
observed.  The  first  one  is  characterized  by  the  invagination  of  the 
oolemma  followed  by  a  spontaneous  breakage.  This  is  the  most 
frequently encountered response and is considered a normal behaviour 
for the membrane. The second pattern consists of a sudden tearing of the 
membrane that  retracts  without forming a funnel.  Explanation for  the 
different  behaviours  of  the  oolemma  can  be  attributed  to  the 
characteristic membrane structure of the human oocyte. In the last years 
the  idea  that  funnel  effect  is  representative  of  adequate  cytoplasm 
maturation has been proposed. Currently, funnel effect is considered a 
reliable indicator of maturation stage of both oolemma and cytoplasm 
(Nagy et al, 1995). In the present study, for the first time data concerning 
the relationship between the stimulation protocol (LH supplementation) 
and the funnel effect is reported. The main finding was the statistically 
significant increase in the percentage of oocytes with funnel effect in the 
group treated with r-FSH plus r-LH. Also in this case the observation 
needs to be confirmed in a larger  sample size.  Anyway, the idea that 
more frequent observation of a funnel effect represents the consequence 
of a more physiological stimulation is consistent with previous literature. 
Several studies demonstrated that LH activity is crucial in regulating last 
stages of both folliculogenesis and oogenesis (Filicori et al., 2003). More 
specifically,  it  has  been  proven  that  embryos  obtained  from  women 
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stimulated with both FSH and LH show a significant  increase in  the 
ploidy  when  compared  with  those  deriving  from  FSH  monotherapy 
(Weghofer et al., 2008). This observation clearly supports the idea that 
LH-dependent changes in the oocytes cytoskeleton occur and that these 
changes clearly conditions gamete competence, including its capability 
in performing meiosis. The mechanism by which hormonal stimulation 
can modify cytoplasm characteristics is difficult to explain. It could be 
argued that  hormonal conditions affect  the cytoskeleton by modifying 
the  quantity  of  cytokeratin,  which  supports  the  hypothesis  that  the 
hormonal milieu can in fact influence oolemma behaviour (Amsterdam 
and Aharoni, 1994).
In both chapters  patients were divided according to age. Interestingly, 
both  percentage  of  mature  oocytes  and  percentage  of  gametes  with 
funnel effect were significantly higher only in subgroups of women l >30 
years.  This  observation  is  consistent  with  previous  comparative  trials 
which  demonstrated  that  LH  supplementation  does  not  modify 
pregnancy  rates  in  younger  patients  but  significantly  increase  this 
parameter  in women >35 years  (Humaidan et  al.,  2004; Marrs  et  al., 
2004). The reason why LH is more effective in elderly women is still 
unclear.  Explanations  fall  into  two  hypothetic  categories:  the  first  is 
based on the concept that LH is crucial in sustaining several granulosa 
activities,  including  growth  factors  and  cytokines;  aging  leads  to  a 
significant  reduction  of  both  quality  and  quantity  of  granulosa  cells, 
which in turn can affect  LH-dependent activities and increase the LH 
requirement (Alviggi et al., 2009). The second hypothesis is related to 
the  LH-dependent  androgen  production  in  theca  cells.  Androgens  are 
crucial  in  follicular  recruitment,  whereas  low  androgen  levels  can 
negatively affect follicular growth and competence (Hillier, 1994). Also 
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in this case,  aging reduced androgen production. This effect  could be 
balanced by exogenous LH.
Finally, the observation that findings concerning  both oocyte maturity 
and  funnel  effect  were  consistent  in  the  same  population  seems  to 
reinforce the idea that LH can improve overall oocyte quality, mainly in 
advanced reproductive age. 
In conclusion, more extended studies on the possible connection between 
hormonal profile and the different membrane behaviours are required. 
The  analysis  of  a  further  series  of  couples  with  oocytes  consistently 
displaying  a  particular  membrane  pattern,  and  the  assessment  of  the 
hormonal milieu of individual follicular fluids would probably help to 
identify the reason for the different membrane behaviours.
33
CHAPTER 3
                 The importance of oocyte scoring as a predictive value for zygotes and 
       embryo quality in patients undergoing IVFcycles. 
INTRODUCTION
1.1 Oocyte physiology
During the 85 days preceding ovulation, a 100 fold increase of oocyte 
volume occurs. This phenomenon is related to the storage of different 
products, including small molecules, amino acids and nucleotides, which 
derives from cumulus-oophorus cells and reach the oocyte by means of 
junction systems and follicular fluid. Granulosa deriving signals are also 
involved  in  the  regulation  of  oocyte  transcriptional  activities,  which 
become maximal at the stage of the tertiary follicle. As a consequence, 
the  gamete  progressively  accumulates  heterogeneous  materials, 
including polypeptides and RNA macromolecules, which will be crucial 
for successive steps of development including the initial stages of zygote 
life.  Given  that  both  gonadotrophins  directly  regulate  granulosa  cells 
activities,  it  could  be  argued  that  LH  indirectly  regulate  variables 
involved in the final step of oocyte maturation and early embryo survival 
(Elder and Dale, 2000; Fair, 2003). 
Various  investigators  showed  that  molecular  communication  between 
oocytes and granulosa cells exists during folliculogenesis (hypothesis of 
an  oocyte-granulosa  cell  regulatory  loop),  essential  for  inducing  and 
coordinating  differentiation  in  the  oocyte  and  in  the  somatic 
compartment. Several molecules are involved in this specific pathway, 
particularly: oocyte growth differentiation factor 9 seems to control the 
physiological syncronization of cytoplasmic and nuclear maturation. The 
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mRNA of epidermal growth factor (EGF) was also found in granulosa, 
cumulus, and oocyte cells, and it acts on granulosa and cumulus cells 
with an anti-apoptotic effect. Growth differentiation factor-9 synthesis is 
activated by EGF in the oocyte, with a positive effect on cumulus cells. 
The expression of EGF seems to be induced by LH in the theca cells, 
and as a molecular cascade it involves granulosa, cumulus, and oocyte 
synthesis of EGF, preserving these cells from an apoptotic destiny. 
In vitro fertilization (IVF) is a common technique in medically assisted 
reproduction that has been continuously improved during the last  few 
decades. Despite this progresses only a minority of the in vitro-embryos 
have the ability to implant and to give a viable pregnancy, probably due 
to  intrinsic  characteristics  of  the  gametes.  In  order  to  guarantee  high 
pregnancy rates, the transfer of a single embryo with high implantation 
potential would be the ideal strategy. For this purpose, the most widely 
supported strategy is to rely on the identification of oocytes prior to fer­
tilization, scoring of pronuclear (PN), stage zygotes (Ebner et al., 2003; 
Germond and Senn, 1999). and the grade of the embryos at the time of 
embryo transfer. 
Denudation  of  cumulus  cells  creates  an  opportunity  to  observe 
morphological  deviations  from  the  so-called  normal.  A good  quality 
metaphase  II  oocyte  is  defined  as  an  oocyte  with  clear,  moderately 
granular cytoplasm, small perivitelline space, and a clear to colourless 
zona pellucida (Veeck, 1988). Most frequently observed morphological 
variations of the oocyte are cytoplasmic and include changes in colour, 
granularity  and  homogeneity  of  the  cytoplasm,  and  cytoplasmic 
incorporations. Extracytoplasmic variations are deviations from normal 
of  perivitelline  space,  zona  pellucida  colour  and  oocyte  shape  (Van 
Blerkom,  1990).   However,  most  of  the  studies  published  so  far 
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examining the effect of clinical parameters on oocyte quality have been 
dependant upon oocyte maturity rather  than morphology. Few articles 
examined  the  effect  of  different  stimulation  protocols  with  different 
types of gonadotrophins on the morphology of the oocyte (Imthurn et al., 
1996; Yu Ng et al.,  2001; Rashidi et  al.,  2005). Imthurn et al.  (1996) 
examined the effect of highly purified follicle stimulating hormone (HP - 
FSH) on nuclear maturity and morphological appearance of the oocyte in 
couples  undergoing  ICSI  and  compared  the  results  with  human 
menopausal  gonadotrophin  (HMG)  stimulation.  Patient  characteristics 
did not differ between the two groups. A significantly higher proportion 
of oocytes in the FSH-HP group were nuclear mature (metaphase II) than 
in  the  HMG  group.  The  percentage  of  oocytes  with  cytoplasmic 
abnormalities  was  similar  between  the  groups.  However,  when  a 
subgroup analysis of these cytoplasmic abnormalities was performed, it 
was evident that significantly fewer oocytes with dark cytoplasm were 
encountered  in  the  FSH-HP  group,  whereas  the  group  of  oocytes 
showing course-grained granulations was similar in both groups. Similar 
fertilization,  cleavage  and  pregnancy  rates  were  obtained  for  both 
groups.  More  recently  Ng  studied  the  effect  of  HMG  versus  FSH 
stimulation  on  oocyte  maturity  as  well  as  on  extracytoplasmic  and 
cytoplasmic morphology of the oocyte (Ng et al., 2001). The percentage 
of mature oocytes (metaphase II) was similar between the groups. The 
incidence of oocytes with extracytoplasmic abnormalities such as  zona 
abnormality  or  first  polar  body  abnormality,  as  well  as  oocytes  with 
cytoplasmic abnormalities was also similar.  Rashidi  et  al.  (2005) also 
showed that nuclear maturity, oocytes with abnormal zona, polar body or 
cytoplasmic  morphology  were  similar  between  the  group  of  patients 
stimulated with either HMG or recombinant FSH.
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                   1.2 Oocyte morphology
     Cytoplasm
In  addition  to  cytoplasmic  inclusions,  apparent  differences  in 
cytoplasmic texture and density have been described (Kahraman et al., 
2000;  Meriano  et  al.,  2001).  Extensive  cytoplasmic  granularity  may 
either be homogeneous, affecting the whole gamete, or centrally located. 
The latter was found to be negatively correlated with ongoing pregnancy 
rate (Kahraman et al., 2000). In contrast, slight or moderate granularity 
has been accepted as a normal feature of oocytes. It is conceivable that 
an increased viscosity of the cytoplasm may constrain cell  organelles 
and/or  pronuclei  in  their  movement  preventing  the  zygote  from 
achieving alignment of both pronuclei or alignment of pronuclei with 
respect  to  the  polar  bodies,  thereby  severely  impairing  polarity  and 
further preimplantation development (Edwards and Beard, 1997; Garello 
et al., 1999).
Zona pellucida
Low expression of the zona proteins by the growing human oocyte may 
indicate reduced developmental potential. A German group (Shen et al., 
2005)  observed  that  oocytes  with  zona  splitting,  probably  caused  by 
mechanical  stress  during  retrieval  or  denudation,  were  exclusively 
associated  with  non-conception  cycles.  Probably,  in  these  cases  the 
patterning of proteins may be temporarily interrupted during formation 
of the extracellular coat. Though these types of oocyte usually show an 
ovoid  shape  it  has  to  be  noted  that  the  zona  is  responsible  for  the 
dysmorphism.  If  both  zona  pellucida  and  oocyte  are  involved  in 
distortion,  corresponding  embryos  run  the  risk  of  developmental 
incompetence.  If  this  shape  dysmorphism  runs  throughout 
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preimplantation development, theoretically, it will result in an a typical 
elongated embryo. This deviation from normal morphology of human 4-
cell  embryos  (Edwards  et  al.,  1970),  which  is  characterized  by  a 
'crosswise' appearance of the blastomeres (with three blastomeres lying 
side by side), may lead to a reduction in cell-to-cell contact points as a 
prerequisite  for  an  optimal  development  of  the  fetus  (Suzuki  et  al., 
1995).  This decrease in the number of available tight  junctions could 
cause  delayed formation  of  the blastocoele  and full  expansion of  the 
blastocyst not before day 6, as indicated by data from zona-free ICSI 
(Ding et al., 1999, Ebner et al., 2004). However, at least one successful 
pregnancy has been reported after replacement of extensively elongated 
embryos (Esfandiari et al., 2005).
It  can  be  stated  that  some  major  anomalies  of  the  oocyte  are  of 
prognostic value in terms of further development,  such as fertilization 
(meiotic  spindle  absence,  vacuolization),  cleavage  (meiotic  spindle 
absence, fragmented first polar body), development to blastocyst stage 
(fragmented first polar body, vacuolization, cytoplasmic viscosity) and 
implantation  (aggregation  of  sER,  zona  defects).  Therefore,  the 
prognostic role of oocyte morphology should not be underestimated. 
Inclusions
Regardless  of  the  consistency  of  the  ooplasm,  numerous  types  of 
cytoplasmic inclusion may be visible under light microscope. In contrast 
to  conventional  IVF,  minor  dysmorphisms,  such  as  incorporations  or 
refractile bodies, are unlikely to have any impact on fertilization rate and 
embryo quality in ICSI patients (De Sutter et al., 1996; Balaban et al., 
1998;  Ebner  et  al.,  2001).  On  the  other  hand,  vacuoles  as  well  as 
aggregations of smooth endoplasmic reticulum (sER) were found to be 
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the  most  apparent  and dynamic  cytoplasmic  features  that  wilI  impair 
developmental capacity of human oocytes. 
Vacuoles
Vacuoles are membrane-bound cytoplasmic inclusions filled with fluid 
that is virtually identical with perivitelline space liquid (Van Blerkom, 
1990). They may vary in both size and number, and it is assumed that 
vacuoles arise either spontaneously (Van B1erkom, 1990) or by fusion of 
pre-existing vesicles derived from the sER and/or Golgi apparatus (El 
Shafie et al., 2000). 
In previous studies, the incidence of vacuoles in metaphase II oocytes 
varied between 5.7% (De Sutter et al., 1996) and 12.4% (Alikani et al., 
1995).  Multiple  vacuoles  accounted  for  only  a  small  part  of 
approximately  1%  (De  Sutter  et  al.,  1996;  Loutradis  et  al.,  1999). 
Interestingly, there is only one ICSI study (De Sutter et al., 1996)  that 
found a severely reduced fertilization rate in vacuolized oocytes (40%) 
compared with gametes without vacuolization (69.6%). 
In theory, it is very likely that a larger vacuole or multiple vacuoles will 
cause a more detrimental effect on the oocyte than a small one, since a 
larger portion of the cytoskeleton (e.g. microtubuli) cannot function as it 
is  supposed to.  In addition,  Van Blerkom (1990)  suggested that  large 
vacuoles may displace the metaphase II spindle from its polar position, 
which  in  turn  can  result  in  fertilization  failure,  cleavage  anomalies 
and/or  an  abnormal  cytokinesis  pattem (Nayudu  et  al.,  1989;  Van 
Blerkom et al., 1990). This is in line with a recent paper (Ebner et al., 
2005) describing a significant correlation between vacuole diameter and 
the  presence  of  two  pronuclei  at  the  zygote  stage.  Interestingly,  no 
fertilizations above a vacuole size of 14 µm occurred in this study. 
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sER cluster
In contrast to vacuolization, the mechanisms responsible for sER clusters 
are  unknown.  Such  aggregations  can  easily  be  distinguished  from 
vacuoles  since  they  are  not  separated  from the  rest  of  the  ooplasmic 
volume  by  a  membrane.  Transmission  electron  microscopic  analysis 
showed that some minor clusters (2-5 1µm) may be overseen using light 
microscopy (Otsuki et al., 2004). Carefully avoiding direct injection of 
the sperm into the sER aggregation gives satisfactory fertilization results. 
Although cell division rates were almost identical in sER cluster-positive 
and negative cycles, biochemical pregnancy rate in the first group was 
significantly  higher (22.2%) compared with unaffected cycles  (3.5%). 
The same negative impact was found for clinical pregnancy rate, since it 
was found to be reduced from 28.2% in unsuspicious oocytes to 5.6% in 
cluster-positive oocytes. In the Otsuki paper (2004), only one pregnancy 
deriving  from  gametes  with  a  sER  defect  has  been  reported,  and, 
unfortunately,  the  baby  was  diagnosed  with  Beckwith-Wiedemann 
syndrome.
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1.3 Computerized biology
The computerized biology is a field in which computer mathematics and 
statistic techniques can be applied to biological problems. This method 
could be useful in order to find a  repeatable system for an objective 
oocyte  selection.  Such discipline proposes to understand the structure 
and the function of biomolecules to understand their structure and the 
relationships  among  them.  The  mathematical,  statistic  and  computer 
methods  for  the  coding images  and recognition  of  a  specific  pattern, 
would be able to collect all the informations and have the possibility to 
compare  them,  with  a  possible  impact  expecially  on  the  biomedical 
research. 
Currently, in IVF techniques, the choice of the three best oocyte to use 
for IVF insemination is based on the operator experience. This project is 
part of a collaboration with the Molecular Biodiversity Laboratory, IBM 
Italy. We bought and managed to set the new system for the acqiuring 
images (Nis-Elements AR Nikon) together with the identification of the 
best  oocyte  morphology parameters that  could best  fit  the aim of the 
project. 
The aim of the project is to elaborate a  functional and efficient software 
that can help the embryologist to select the best oocytes. The goal is to 
find  a  correlation  between  these  oocytes,  zygotes  and  embryonic 
morphology, moreover with clinical outcome. 
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MATERIALS AND METHODS
Oocyte morphology assessment
For  this  study  we  considered  an  unselected  population.  Ovarian 
stimulation protocol, oocytes retrieval and ICSI procedure had already 
been specified in chapter 1 and 2. 
Morphological  abnormalities  of  a  metaphase  II  (MII)  oocyte  after 
retrieval and denudation of the corona-cumulus layer were collected in a 
data base (Table 8) and examined.     
TIME OF OBSERVATION: 1 2 3 4 5 6 7 8 9 10
POLAR BODY
                 Intact
                 Fragmentated          
PERIVITELLINE SPACE
                 Small
                 Large
                 Absent
                 Granular
CYTOPLASM
                 Clear/homogeneous
                  Dark
Disomogeneous
                  Granular
INCLUSIONS
                                                          Yes
                                                            No
 VACUOLES
No
Small
Large
POLARITY
Yes
No
ZONA PELLUCIDA
Normal
Yellowish
Thin
Thick
Disomogeneous
REFRACTILE BODIES  
Yes
No
OTHER:
      
      Table 8. Oocyte scoring table
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Zygote scoring
In vitro fertilization (IVF) human pronucleate zygotes are scored on the 
basis of pronuclear alignment, size, number, equality and distribution of 
nucleoli,  cytoplasmic  heterogenicity  and  presence  or  absence  of 
cytoplasmic halos (Scott et al., 1998; Kattera et al 2004; Ebner et al., 
2003; Demirel et al., 2001)  Unfortunately, there is no standard zygote 
grading  system used  in  assisted  reproduction  laboratories.  Two  main 
systems for assessing pronuclear morphology were developed by Scott 
and Smith (1998) and Tesarik (2000).
At 16–18h after insemination, fertilization was assessed by observing the 
presence  of  2PN and two polar  bodies under  an inverted microscope 
equipped with  Hoffman modulation  contrast.  Zygotes  observed under 
Hoffman contrast  (X200 magnification) were photographed to use the 
scoring system as a tool to evaluate the effects of different pattern. The 
zygotes were scored according to the  Tesarik et al. classification. The 
system  took  account  of  nuclear  size  and  alignment  and  nucleoli 
(nucleolar  precursor  bodies,  NPB)  number  and  distribution.  Briefly, 
2PNP0 zygotes  had equal  numbers  of  NPB aligned at  the  pronuclear 
junction. The absolute number was not counted but was between three 
and six. 2PNP1  zygotes had small sized, unequal and scattered nucleoli. 
2PNP2 zygotes had large sized and scattered nucleoli. 2PNP3 had small 
sized, allined at the pronuclear junction. 2PNP4 had unequal number but 
equal sizes of nucleoli (between three and six) aligned at the pronuclei 
junction. 2PNP5 zygotes had unequal number and sizes of NBP but with 
one nucleus having alignment at the pronuclear junction and the other 
with scattered nucleoli. Zygotes with separated, very different sizes or 
periphery located pronuclei were classified as “not classified” (Figure 2).
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       Figure 2. Zygote scoring
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Day 2 embryo scoring
The  morphology  of  an  embryo  was  noted  20-24h  (day2)  after 
insemination.  The  embryos  were  scored  as  “good  or  bad”  quality 
according  to  degree  of  cytoplasm  fragmentation  and  the  number  of 
blastomeres. Grade “good quality embryos” contained the best embryos: 
at  least  2  blastomeres  (2-4  blastomeres)  and  maximum  10%  of 
cytoplasm fragmentation. Grade B embryos have 7-9 cells also but with 
over 20% of cytoplasmic fragmentation. Grade C has 4-6 cells embryos 
with  maximum  20%  fragmented  cytoplasm  and  finally  grade  D, 
contained the worst (morphologically lower) embryos with 4-6 cells and 
over 20% of fragmentation (Figure 3).
Figure 3. Embryo scoring
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Acquiring images system
This software allows us to acquire, to elaborate and to file the images by 
applying  a  camera  on  the  inverted  microscope,  used  for  the  ICSI 
procedures, which can be connected with a monitor. In this part of the 
project we managed to set different ranges for each oocyte parameters in 
order to create a correct data base to collect these different measurements 
(Table 9 and 10). This step is followed by the observation of the oocyte 
"tracking" (the follow-up of the oocyte during each of the IVF steps). 
Statistical analysis
The results are reported as the mean ± SD. Data were analysed with the 
SPSS version 12.0 (SPSS Inc.,  USA).  One-way ANOVA was used to 
determine the effect of the stimulation protocol on continuous variables. 
Correlations between continuous variables were performed with Pearson 
correlation coefficient test. The post hoc The Mann–Whitney U-test was 
applied to test differences between groups for continuous variables with 
non-parametric  distributions;  2  statistics  were  used  to  compare 
discontinuous  data.  A  p value  <0.05  was  considered  statistically 
significant.
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Table 9 Software database
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Oocytes morphological 
parameters
              Range  
       
Value Manual 
measurments
Polar body    
                         Diameter if intact             14-16 μm 1
Measure the 
diameter as a 
distance between 
two points 
                         Fragmentated
Zona pellucida lenght   
         15 - 20 μm 2
Measure the 
thickness in 4 
points: 3, 6, 9, 12 
o'clock and write 
the average 
number 
Oocyte Diameter   
       115 - 165 μm 1
Trace the oocyte 
area by using 
different points 
on the oocyte at 
3and  6 o'clock, 
under the 
pipette,at 12 
o'clock above the 
pipette. Write the 
circumferance's 
diameter.
Refractile bodies   
                          Absence  3  
                          Presence diameter <5 μm
Consider 3 
different points 
and trace the 
circumferance 
Write the 
dimeter.
                          Presence diameter >5 μm
    
   
                  
Table 10 Software database
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Perivitelline Space  Range Value
      Manual 
Measurements
14-16 μm 2
Measure the 
thickness as a 
distance between 
points nearby the 
polar body
Vacuoles   
                           Absence 3
                          Presence diameter <9 μm
Measures as 
refractile bodies  
                          Presence diameter >10 μm
Polarity   
                           Presence 1
Measure the area by 
fixing different 
points of the region
                           Absence
Citoplasm   
              Uniform/Clear/medium granulosity 1
Automatic 
measurement
              Uniform/Dark/high granulosity 
RESULTS
A total  of  190 oocytes were analysed and morphologically  evaluated. 
The entire population was divided into two groups based on the oocyte 
cytoplasmic morphology. 
Group 1. Oocytes with clear and homogeneous cytoplasm 
Group 2. Oocytes with dark and granular cytoplasmic
Of the 190 oocyte collected, 38.9% (n = 74) were retrieved in group 1 
and 61.05% (n = 116) in group 2 (Figure 4).
Group 1 and group 2 oocytes were evaluated for  the presence of the 
polarity. For group 1, 63.5% (n = 47) oocytes showed a polarity while 
only the 31% (n = 36) in group 2 oocytes. (Table 11)
Clear  and  homogenous  cytoplasm is  significantly  correlated  with  the 
presence of polarity phenomenon. (p <0.001). 
Based on these results we analysed the combination between this two 
parameters  (clear-homogeneous  cytoplasm  and  polarity)  and  zygotes 
quality. We considered 6 different pattern one of which classified all non 
developed  zygotes.  Nevertheless,  the  association  didn’t  show  any 
statistical significance (p = 0.87),  we could observe that oocytes with 
clear  and  homogeneous  cytoplasm  and  polarity  presence  showed  a 
higher percentage of good zygotes quality. In particular: 
 group 1 (oocytes with clear and homogeneous cytoplasm and presence of 
polarity) correlates with the 29.8% (n = 14) of good quality zygotes: 
pattern 0 (Table 12; Figure 13);
 group  2  (oocytes  with  dark  granularity  cytoplasm  and  presence  of 
polarity)  correlates  with  the  11.1% (n =  4)  of  good  quality  zygotes: 
pattern 0 (Table 12; Figure 14).
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(Pronuclear and embryo scoring were assessed too.) 
We  than  evaluated  the  impact  of  clear-homogeneous  oocyte 
cytoplasm  on day 2 embryo quality. 
Embryo quality was divided in two groups:
1. Embryos of good quality (grade 1 and 2)
2. Embryos of bad quality (grade 3,4 and 5) 
We observed a total of 190 embryos. 166 (87%) embryos were 
classified  in  group  1,  95  (57%)  of  which  presented  clear-
homogeneous cytoplasm and 71 (43%) presented dark-granular 
cytoplasm. A total of 24 (13%) embryos were classified in group 
2.  18  (75%)  group  2  embryos  showed  clear-homogeneous 
cytoplasm, while 6 (25%) showed a dark-granular cytoplasm.
Statistical  analysis  underlined  a  significant  association 
between  clear-homogeneous  cytoplasm  and  good  embryo 
quality [p = 0.09 (Table 13)]
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Group 1 Group 2
Percentage of 
polarity presence
  63.5(47) 31(36)
Percentage of 
polarity absence
  36.5(27)  69(80)
Table 11. Evaluation of the presence of polarity in clear-homogeneous 
      (group 1) and dark-granular (group 2) oocytes
Χ2 p = 0.0001 
Group 1 Group 2
Percentage of 
pattern 0(2PNp0)
  29.8(14) 11.1(4)
Percentage of 
pattern 1-5 
  70.2(33)  88.9(32)
Table 12. Pattern 0 and pattern 1-5 in clear-homogeneous and dark- 
      granular oocytes 
 
Χ2 p = 0.0755 
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Group A (“good” 
embryo)
Group B (“bad” 
embryo)
Percentage of 
embryo from 
oocyte with 
clear- 
homogeneous 
cytoplasm
  57(95) 75(18)
Percentage of 
embryo from 
oocyte with 
dark-granular 
cytoplasm  
  43(71)  25(6)
Table 13. Good embryos (group A) and bad embryos (group B) deriving 
       from clear-homogeneous and dark-granular cytoplasm 
Χ2 p = 0.1512 
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Figure 11. Number of MII oocyte with either clear-homogeneous
                  nor dark-granular cytoplasm
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Fertilized MII oocyte 
74
116
MII oocyte with 
clear- 
  homogeneous
  cytoplasm
MII oocyte with
    dark- granular 
    cytoplasm
Figure 12. Presence of polarity in MII injected oocyte with clear- 
        homogeneous or dark-granular cytoplasm
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Figure 13. Zygotes from injected MII oocyte with clear-homogeneous
                  cytoplasm and polarity
ZYGOTES FROM OOCYTES WITH CLEAR-HOMOGENEOUS 
CYTOPLASM + POLARITY 
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C
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ZYGOTES FROM OOCYTE WITH DARK-GRANOLOUS 
CYTOPLASM + POLARITY
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Figure 14. Zygotes from injected MII oocyte with dark-granolous
        cytoplasm and polarity.
DISCUSSION
In this study we included all women that underwent ICSI procedure. We 
focused our attention on oocyte quality in order to find a morphological 
parameter that could predict a good zygote and embryo quality. A data 
base  was  created  to  collect  all  oocytes  morphological  informations, 
while demographic, anthropometric and hormonal characteristics for this 
unselected population were collected in a different data base.
Cytoplasm aspect is an important parameter because includes all of the 
organelles that play an important role on the activation of the oocytes 
competence  at  the  time  of  the  spermatozoon  entrance.  Extensive 
cytoplasmic granularity may either be homogeneous, affecting the whole 
gamete,  or  centrally  located.  The  latter  was  found  to  be  negatively 
correlated  with  ongoing  pregnancy  rate (Kahraman  et  al.,  2000) 
Moreover,  an increased viscosity of the cytoplasm may constrain cell 
organelles or pronuclei in their movement preventing the zygote from 
achieving  alignment  of  both  pronuclei,  thereby  severely  impairing 
polarity and further preimplantation development (Edwards and Beard, 
1997; Garello et al., 1999). 
Based  on  the  literature  background,  we  focused  our  interest  on 
cytoplasm morphology and on the presence of polarity in MII oocytes 
and on their impact on zygotes and embryo quality. We analysed 190 
oocytes  and  we  observed  that  116  oocytes  had  a  clear-homogeneous 
cytoplasm and 74 had a dark-granular one. 
One  of  the  other  oocytes  parameters  observed  was  the  presence  of 
polarity. This phenomenon is probably the result of an intense ribosomal 
activity  in  a  specific  region of  the  oocyte  that  could have  a  positive 
significance.  This  last  statement  needs  still  to  be  supported  by  other 
studies because in literature only two studies had been published until 
57
now. We, than, decided to see if the presence of polarity could be related 
to the cytoplasm morphological aspect. With this investigation we saw 
that the number of oocytes with dark-granular cytoplasm that showed 
polarity was lower than the group of oocytes with clear-homogeneous 
cytoplasm and this result was statistically significant.
To support the theory that clear-homogeneous cytoplasm and presence of 
polarity could be considered two predictive parameters we followed the 
development  of  these  injected  oocytes.  Injected  MII  oocyte  show 
different  zygotes  pattern  on  day  1  and  recent  studies  showed  that 
pronuclear zygote morphology might predict the outcome of IVF (Payne 
et al., 2005). 
Our preliminary data demonstrates that the best pattern, 2PNP0  zygotes, 
derives  from oocyte  with clear-homogeneous  cytoplasm and  polarity. 
But this data didn't show any statistically significance. Neverthless, the 
relationship between these parameters can be considered a starting point 
from which we can create a good oocyte selection system but further 
observations need to be done in order to have a higher number of sample 
to analyse. 
In most of the oocyte morphology studies embryo quality is the ending 
point because embryo scores are still accepted  as the best predictor of 
pregnancy for IVF (Fisch et al., 2003; Laasch and Puscheck, 2004),
The quality of embryos has traditionally been  evaluated based on the 
cleavage  rate  and blastomere  morphology.  However,  these  criteria  by 
themselves lack sufficient sensitivity and specificity in the prediction of 
pregnancy rates.  In  the last  phase of  the study we observed embryos 
development. We divided them into two main groups: “good” and “bad” 
quality  embryos.  Even  in  this  results  we  didn't  find  any  statistically 
significance probably due to the poor number of observations. 
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In  conclusion,  the  data  presented  in  this  study  show that  the  oocyte 
scoring might be a more immediate predictive value for  the entire IVF 
cycle. A good  quality  cytoplasm can  predict  a  polarity  presence  and 
when both good quality cytoplasm and presence of polarity appear in the 
same oocyte,  they can predict  the best  zygote quality.  About 50% of 
recruited oocyte presents both characteristics and the embryologist need 
to be able to find them and to choose them in order to give the patient the 
highest possibility of a positive result for their IVF cycle. Moreover, we 
can state that clear-homogeneous cytoplasm can be considered a good 
embryo quality parameter. So, based on oocyte scoring system we could 
decrease the number of injected oocyte and sovranumerary oocyte can 
either be thawed or used for research but further investigations should be 
done in order to increase its predictive value.
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Some images captured by the software
Polar body measurement 
  Inclusion measurement
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   Refractile body measurement
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